FRCPC MD - VBI Vaccines Chief Officer
Insider
FRCPC MD is Chief Officer of VBI Vaccines
| Age | 67 |
| Phone | 617 830 3031 |
| Web | https://www.vbivaccines.com |
VBI Vaccines Management Efficiency
The company has return on total asset (ROA) of (0.2915) % which means that it has lost $0.2915 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.1959) %, meaning that it created substantial loss on money invested by shareholders. VBI Vaccines' management efficiency ratios could be used to measure how well VBI Vaccines manages its routine affairs as well as how well it operates its assets and liabilities.VBI Vaccines currently holds 53.04 M in liabilities with Debt to Equity (D/E) ratio of 0.32, which is about average as compared to similar companies. VBI Vaccines has a current ratio of 2.24, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about VBI Vaccines' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Fuad Ahmad | Vaxart Inc | 54 | |
| Ian MBA | Jaguar Animal Health | 57 | |
| Karen Harrigan | Ardelyx | N/A | |
| Stephen Cheng | Allogene Therapeutics | N/A | |
| Michael Hoffman | Annovis Bio | 69 | |
| Christine Cassiano | Allogene Therapeutics | N/A | |
| James MD | Vaxart Inc | 59 | |
| CPA JD | Jaguar Animal Health | 60 | |
| Tiffany MBA | Ocugen Inc | N/A | |
| FACS FACS | Allogene Therapeutics | 73 | |
| Claudine Bruck | Annovis Bio | 65 | |
| Reid McCarthy | Annovis Bio | 66 | |
| Daniel MD | Tonix Pharmaceuticals Holding | N/A | |
| Michael Shine | Ocugen Inc | N/A | |
| Nick DeLong | iBio, Common Stock | N/A | |
| Vijay Tammara | Ocugen Inc | 64 | |
| CPA CPA | Ocugen Inc | 47 | |
| FACP MD | Ocugen Inc | N/A | |
| Veer Bhavnagri | Allogene Therapeutics | 41 | |
| Mike Jenkins | iBio, Common Stock | N/A | |
| David Sesin | Jaguar Animal Health | N/A | |
Management Performance
| Return On Equity | -4.2 | |||
| Return On Asset | -0.29 |
VBI Vaccines Leadership Team
Elected by the shareholders, the VBI Vaccines' board of directors comprises two types of representatives: VBI Vaccines inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VBI. The board's role is to monitor VBI Vaccines' management team and ensure that shareholders' interests are well served. VBI Vaccines' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, VBI Vaccines' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Adam Buckley, Vice President - Operations and Project Management | ||
| FRCPC MD, Chief Officer | ||
| FCMA FCMA, CEO Pres | ||
| Christopher McNulty, CFO and Head of Business Development | ||
| Nicole Anderson, Director Relations | ||
| Avi Mazaltov, Global SciVac | ||
| Misha Nossov, Senior Europe | ||
| David Anderson, Chief Scientific Officer | ||
| Jeffery FCMA, CEO President | ||
| Nell Beattie, Chief Officer | ||
| Athena Kartsaklis, Principal Financial and Accounting Officer, Senior Vice President - Finance, Chief Compliance Officer, Corporate Controller | ||
| John Dillman, Chief Officer |
VBI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is VBI Vaccines a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.2 | |||
| Return On Asset | -0.29 | |||
| Operating Margin | (9.68) % | |||
| Current Valuation | 38.92 M | |||
| Shares Outstanding | 28.68 M | |||
| Shares Owned By Insiders | 6.76 % | |||
| Shares Owned By Institutions | 13.00 % | |||
| Number Of Shares Shorted | 276.87 K | |||
| Price To Earning | (3.79) X | |||
| Price To Book | 1.24 X |
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |